Drug · DIN 00400688
PROSTIN E2 TABLETS
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since July 29, 2026; first marketed December 31, 1977.
- Drug Identification Number (DIN)
- 00400688
- Company (DIN owner)
- Pfizer Canada UlcKirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Dinoprostone G02AD02
- Class
- Human
- Record last updated
- August 6, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DINOPROSTONE | 0.5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 29, 2003: NOC 461New Drug Submission (NDS) · Manufacturer name change
- July 19, 2001: NOC 2161New Drug Submission (NDS) · Manufacturer name change
- September 16, 1997: NOC 3740New Drug Submission (NDS)